BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 8596038)

  • 21. Contribution of the TCR alpha-chain to the differential recognition of bacterial and retroviral superantigens.
    Daly K; Nguyen P; Hankley D; Zhang WJ; Woodland DL; Blackman MA
    J Immunol; 1995 Jul; 155(1):27-34. PubMed ID: 7602104
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TCR reactivity in human nickel allergy indicates contacts with complementarity-determining region 3 but excludes superantigen-like recognition.
    Vollmer J; Weltzien HU; Moulon C
    J Immunol; 1999 Sep; 163(5):2723-31. PubMed ID: 10453014
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of two V beta 7-specific viral superantigens.
    Ignatowicz L; Kappler JW; Marrack P; Scherer MT
    J Immunol; 1994 Jan; 152(1):65-71. PubMed ID: 8254207
    [TBL] [Abstract][Full Text] [Related]  

  • 24. T cell receptor V alpha 4 is expressed by a subpopulation of V beta 6 T cells that respond to the bacterial superantigen staphylococcal enterotoxin B.
    Borrero H; Donson D; Cervera C; Rexer C; Macphail S
    J Immunol; 1995 May; 154(9):4247-60. PubMed ID: 7722285
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New infectious mammary tumor virus superantigen with V beta-specificity identical to staphylococcal enterotoxin B (SEB).
    Luther S; Shakhov AN; Xenarios I; Haga S; Imai S; Acha-Orbea H
    Eur J Immunol; 1994 Aug; 24(8):1757-64. PubMed ID: 8056034
    [TBL] [Abstract][Full Text] [Related]  

  • 26. I-J revisited: is the I-J genetic restriction in downregulation due to an endogenous superantigen analogous to mammary tumour virus (Mtv)-encoded endogenous superantigen?
    Asherson GL; Dieli F; Tomonari K
    Folia Biol (Praha); 1994; 40(6):341-7. PubMed ID: 7589693
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Variable influence of MHC polymorphism on the recognition of bacterial superantigens by T cells.
    Wen R; Blackman MA; Woodland DL
    J Immunol; 1995 Aug; 155(4):1884-92. PubMed ID: 7636239
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of natural killer cells by mouse mammary tumor virus C4 in BALB/c and T-cell receptor V beta 2-transgenic mice.
    Gill R; Wang H; Bluethmann H; Iglesias A; Wei WZ
    Cancer Res; 1994 Mar; 54(6):1529-35. PubMed ID: 8137259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene transfer directly demonstrates a role for TCR V alpha elements in superantigen recognition.
    Donson D; Borrero H; Rutman M; Pergolizzi R; Malhado N; Macphail S
    J Immunol; 1997 Jun; 158(11):5229-36. PubMed ID: 9164940
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Presentation of the Mls-1 superantigen by human HLA class II molecules to murine T cells.
    Subramanyam M; McLellan B; Labrecque N; Sekaly RP; Huber BT
    J Immunol; 1993 Sep; 151(5):2538-45. PubMed ID: 8395548
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deletion of CD4+ T cells by mouse mammary tumor virus (FM) superantigen with broad specificity of T cell receptor beta-chain variable region.
    Yoshimoto T; Nagase H; Nakano H; Matsuzawa A; Nariuchi H
    Virology; 1996 Sep; 223(2):387-91. PubMed ID: 8806576
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The induction of peripheral tolerance by the chronic activation and deletion of CD4+V beta 5+ cells.
    Fink PJ; Fang CA; Turk GL
    J Immunol; 1994 May; 152(9):4270-81. PubMed ID: 7908916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Conserved amino acid residues in the complementarity-determining region 1 of the TCR beta-chain are involved in the recognition of conventional Ag and Mls-1 superantigen.
    Kang J; Chambers CA; Pawling J; Scott C; Hozumi N
    J Immunol; 1994 Jun; 152(11):5305-17. PubMed ID: 8189048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of an endogenous mammary tumor virus involved in the clonal deletion of V beta 2 T cells.
    Jouvin-Marche E; Marche PN; Six A; Liebe-Gris C; Voegtle D; Cazenave PA
    Eur J Immunol; 1993 Nov; 23(11):2758-64. PubMed ID: 8223851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clonal heterogeneity of superantigen reactivity in human V beta 6+ T cell clones. Limited contributions of V beta sequence polymorphisms.
    Goronzy JJ; Oppitz U; Weyand CM
    J Immunol; 1992 Jan; 148(2):604-11. PubMed ID: 1530864
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of a new type of invariant V alpha 14+ T cells and responsiveness to a superantigen, Yersinia pseudotuberculosis-derived mitogen.
    Yagi J; Dianzani U; Kato H; Okamoto T; Katsurada T; Buonfiglio D; Miyoshi-Akiyama T; Uchiyama T
    J Immunol; 1999 Sep; 163(6):3083-91. PubMed ID: 10477573
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MHC control of the naive TCR alpha-chain repertoire.
    Merkenschlager M; Benoist C; Mathis D
    J Immunol; 1994 Oct; 153(7):3005-13. PubMed ID: 8089483
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Physiologic expression of two superantigens in the BDF1 mouse.
    Gollob KJ; Palmer E
    J Immunol; 1991 Oct; 147(8):2447-54. PubMed ID: 1655891
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic modulation of the TCR repertoire in the lymphoid periphery.
    Blish CA; Gallay BJ; Turk GL; Kline KM; Wheat W; Fink PJ
    J Immunol; 1999 Mar; 162(6):3131-40. PubMed ID: 10092762
    [TBL] [Abstract][Full Text] [Related]  

  • 40. T cell repertoire and clonal deletion of Mtv superantigen-reactive T cells in mice lacking CD4 and CD8 molecules.
    Penninger JM; Schilham MW; Timms E; Wallace VA; Mak TW
    Eur J Immunol; 1995 Jul; 25(7):2115-8. PubMed ID: 7621886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.